LexaGene Holdings Inc.
Not enough financial coverage to compute a composite score for LXG.V. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.lexagene.com
LexaGene Holdings Inc. , a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
- CEO
- John F. Regan
- IPO
- 2018
- Employees
- 33
- HQ
- Beverly, MA, US
Performance & Tape
- 52W High
- $0.30
- 52W Low
- $0.07
- 50D MA
- $0.18
- 200D MA
- $0.17
- Beta
- 2.26
- Avg Volume
- 104.40K
Get TickerSpark's AI analysis on LXG.V
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our LXG.V Coverage
We haven't published any research on LXG.V yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LXG.V Report →